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Background: Reports on burden of hepatitis C and hepatitis B
virus (HCV/HBV) are a big challenge for district to minimize the
transmission of associated risk factors. Study was conducted to
know the prevalence ofHCV/HBV infection in pregnantwomen and
their blood donors attended a surgical referral clinic for cesarean
delivery. Study was therefore undertaken to determine the preva-
lence of HCV/HBV infection among pregnant women and their
blood donors.
Methods&Materials: A cross-sectional analytical study (record
review) of all pregnant women and their blood donors (family
members) was conducted from 10th to 15th February 2015 at a
private surgical clinic in district Naushahro feroze. Data from 1st
January to 31stDecember 2014gatheredon results of blood screen-
ing used by ELISA test.
Results:Of175womenaged15–52years, 13%(n=22) testedpos-
itive (13HCV; 9HBV) besides these a total of 656 blood donors aged
16-40 years reported for blood donations and were 22%(n=145)
tested positive (80 HCV; 65 HBV). The highest positivity rate was
seen in women aged 25 years or less(26%) compared with those
aged above 25 years (9%) OR=3.02 (95% CI 1.03 to 9.98). Statisti-
cally signiﬁcant difference was identiﬁed between ages of donors
whowere aged below 25 yearswere high positivity rate(30%) com-
pared to above 25 years positive for hepatitis infection(24%) OR=
1.15. 02 (95% CI 1.01 to 2.34).
Conclusion: One in eight pregnant women attending surgi-
cal clinic for cesarean delivery and one in ﬁve blood donors who
came to attend for bleed has evidence of HCV/HBV infection. These
HCV/HBV positivemothersmay be at increased risk of transmitting
HCV/HBV infection to their unbornbabies.We suggest that all preg-
nant women attending 1st antenatal care be tested for HCV/HBV
infection; exposed babies need to receive HBV vaccines at birth.
Further molecular studies on risk factors should be carried out at
these settings.
http://dx.doi.org/10.1016/j.ijid.2016.02.928
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Background: Signiﬁcance of diagnostic kits evaluation for
emerging dengue infection
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Dengue is an arthropod borne ﬂavi virus that includes of four
serotypes (Den-1,Den-2,Den-3andDen4) that comprisesonmulti-
ple antigenic complex of family ﬂavi viridae. Dengue virus infection
causes range of clinical manifestations from asymptomatic and
symptomatic as Dengue Fever (DF), Dengue Hemorrhagic fever
(DHF) and Dengue Shock syndrome (DSS). Dengue cases aremostly
asymptomatic fever with or without rashes. Within acute stage of
infection, diagnostic conﬁrmation is vital to recover the patients.
The patients progress DHF/ DSS, which can result in death if it
is not timely and managed appropriately. Although there are no
speciﬁc antiviral drugs or vaccine for dengue infection, patient usu-
ally recovers with the appropriate management (ﬂuids). Therefore,
accurate and timely diagnosis and conﬁrmation test have a key role
in patient management and control. Many of the kits are commer-
cially available for diagnosis of dengue infection.
Methods&Materials: The rapiddetection technologiespropose
the guarantee fast and improved diagnostic for early detection and
case management, but accuracy of the results has to be conﬁrmed
by evaluating the kit sensitivity, speciﬁcity and cross reactivity.
Hence, the IgM, IgG, NS1 and Rapid immune chromatographic tests
were evaluated and conﬁrmed the results interpretations.
Results: The sensitivity of rapid immune chromatographic test
was 97% and 91% speciﬁcity with 95% CI. Therefore this rapid diag-
nosis kit would be a ﬁrst line diagnosis for dengue infection.
Conclusion: The rapid diagnostic kit is a promising technique
to detect both primary and secondary dengue infections
http://dx.doi.org/10.1016/j.ijid.2016.02.929
